Daniel Granderson

Business Insights
Saudi Arabia IVD market rose to $605M in 2022: Kalorama
The market was driven in part by COVID-19 testing, with about 44 million PCR COVID-19 tests performed through last August.
June 19, 2023
Business Financial Results Social
Business Insights
India IVD market sales rose to $1.4B in 2022: Kalorama Information
According to Kalorama's forecasts, India’s IVD market will increase at a compound annual growth rate (CAGR) of 2.4% from 2022 to 2027.
April 26, 2023
Financials Growth Revenue Business Social
Business Insights
Mexico IVD sales reach $794M: Kalorama Information
Immunoassays are Mexico’s leading IVD segment, followed by point-of-care and microbiology/molecular. Other POC, other molecular, and flow cytometry will be key segments to watch in coming years.
April 11, 2023
Business Economics Pie Chart Social
Business Insights
China worth watching in $3.95B world market for molecular POC tests: Kalorama Information
Central and provincial governments have played a significant role in the expansion of the POC testing market in China.
February 22, 2023
Mpoc Figure
Emergency Use Authorization
COVID-19 tests attempt to prove at-home testing concept can work
These COVID-19 tests were granted separate emergency use authorizations (EUAs) from the U.S. Food and Drug Administration (FDA) earlier in 2021 and all require nasal swab specimens from patients.
August 22, 2021
2021 08 18 22 53 0531 Covid 19 Self Swab Test 400
Page 1 of 1
Top Stories
Proscia Embeddings
Artificial Intelligence
Proscia launches pathology AI model toolkit
Proscia has launched Concentriq Embeddings for experimenting with multiple pathology artificial intelligence (AI) models in parallel.
Crispr Cas9 Gene Editing
Emerging Technology
CRISPR patent decisions could trigger waves globally
Doctor Patient Consult
Pathology and AI
Ibex survey indicates some comfort with AI in cancer diagnostics
Olfactory Bulb Brain Cr Social
Pathology and AI
Pathologists detect microplastics in human brain tissue
Body composition in patients treated with Ozempic
Sponsor Content
Body composition in patients treated with Ozempic
More in Home
Proscia launches pathology AI model toolkit
By Liz Carey
Proscia has launched Concentriq Embeddings for experimenting with multiple pathology artificial intelligence (AI) models in parallel.
October 2, 2024
Proscia Embeddings
CRISPR patent decisions could trigger waves globally
By LabPulse.com staff writers
Canceling a pair of patents in Europe will affect a broad network of biotech companies that have bought and sold the rights to pursue gene-slicing research, according to a September 25 report published in MIT Technology Review.
September 30, 2024
Crispr Cas9 Gene Editing
Ibex survey indicates some comfort with AI in cancer diagnostics
By LabPulse.com staff writers
A recent survey reports that more than 50% of U.S. adults have received an incorrect medical test result for themselves or a loved one. Additionally, 60% would trust artificial intelligence (AI) supporting medical diagnoses.
September 25, 2024
Doctor Patient Consult
Pathologists detect microplastics in human brain tissue
By Will Morton
Pathologists have detected microplastics in the olfactory bulb brain tissues of eight deceased individuals in Sao Paulo, highlighting the need for further research about their effects on human health, reports a study published in JAMA Network Open.
September 25, 2024
Olfactory Bulb Brain Cr Social
NIH establishes pandemic preparedness research network
By LabPulse.com staff writers
The U.S. National Institutes of Health (NIH) has established a pandemic preparedness research network for research on the pathogens that are most likely to threaten human health.
September 19, 2024
Infectious Diseases Research Social
CDC adds commercial lab contracts for infectious disease, bird flu testing
By Liz Carey
Clinical laboratories incentivized to develop diagnostic tests earlier.
September 17, 2024
Colorized transmission electron micrograph of avian influenza A H5N1 virus particles shown in yellow.
Multiregional clinical trial data on FDA watch for U.S. applicability
By LabPulse.com staff writers
Pivotal trials drawing on foreign clinical data in focus.
September 16, 2024
Fda Sign Dc Social
Seegene launches 3rd RUO mpox assay
By LabPulse.com staff writers
After introducing two research use only (RUO) mpox assays in August, Seegene has expanded its mpox assay line with a third RUO assay designed to address the spread of the mpox virus variant clade Ib currently prevalent in the mpox outbreak in Africa.
September 10, 2024
3 D Monkeypox Infecting Cell Social
Hospital labs targeted in proposed Calif. hospital licensing regulations
By Liz Carey
Proposed changes could require some hospitals to materially alter their current operations, according to advisers.
September 11, 2024
Regulation Wheel Social
HudsonAlpha Institute gets $2.9M NIH grant for pediatric rare disease sequencing
By LabPulse.com staff writers
Scientists at the HudsonAlpha Institute for Biotechnology in Huntsville, AL, have been awarded a five-year, $2.9 million U.S. National Institutes of Health (NIH) grant to identify genetic contributors to rare diseases in children.
September 6, 2024
Dna Sequencing Data Analysis Social
ADLM releases guidance for blood lipid assessment, lipoprotein testing
By LabPulse.com staff writers
Document outlines recommendations for standardizing clinical lipid testing workflows.
September 4, 2024
Blood Test Samples Lab Social
Seegene, Springer Nature launch PCR innovation program
By LabPulse.com staff writers
Molecular diagnostics firm Seegene and Springer Nature have launched a new project for the development of diagnostic assays, as part of their ongoing strategic partnership.
September 3, 2024
Research Money Social
Page 1 of 125
Next Page